BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21357306)

  • 1. Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
    Zoraghi R; See RH; Axerio-Cilies P; Kumar NS; Gong H; Moreau A; Hsing M; Kaur S; Swayze RD; Worrall L; Amandoron E; Lian T; Jackson L; Jiang J; Thorson L; Labriere C; Foster L; Brunham RC; McMaster WR; Finlay BB; Strynadka NC; Cherkasov A; Young RN; Reiner NE
    Antimicrob Agents Chemother; 2011 May; 55(5):2042-53. PubMed ID: 21357306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities.
    Zoraghi R; Worrall L; See RH; Strangman W; Popplewell WL; Gong H; Samaai T; Swayze RD; Kaur S; Vuckovic M; Finlay BB; Brunham RC; McMaster WR; Davies-Coleman MT; Strynadka NC; Andersen RJ; Reiner NE
    J Biol Chem; 2011 Dec; 286(52):44716-25. PubMed ID: 22030393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.
    Zoraghi R; See RH; Gong H; Lian T; Swayze R; Finlay BB; Brunham RC; McMaster WR; Reiner NE
    Biochemistry; 2010 Sep; 49(35):7733-47. PubMed ID: 20707314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents.
    Kumar NS; Amandoron EA; Cherkasov A; Finlay BB; Gong H; Jackson L; Kaur S; Lian T; Moreau A; Labrière C; Reiner NE; See RH; Strynadka NC; Thorson L; Wong EW; Worrall L; Zoraghi R; Young RN
    Bioorg Med Chem; 2012 Dec; 20(24):7069-82. PubMed ID: 23141418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further investigation of inhibitors of MRSA pyruvate kinase: Towards the conception of novel antimicrobial agents.
    Labrière C; Gong H; Finlay BB; Reiner NE; Young RN
    Eur J Med Chem; 2017 Jan; 125():1-13. PubMed ID: 27643559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.
    Axerio-Cilies P; See RH; Zoraghi R; Worral L; Lian T; Stoynov N; Jiang J; Kaur S; Jackson L; Gong H; Swayze R; Amandoron E; Kumar NS; Moreau A; Hsing M; Strynadka NC; McMaster WR; Finlay BB; Foster LJ; Young RN; Reiner NE; Cherkasov A
    ACS Chem Biol; 2012 Feb; 7(2):350-9. PubMed ID: 22066782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a 1,2-bis(3-indolyl)ethane that selectively inhibits the pyruvate kinase of methicillin-resistant Staphylococcus aureus over human isoforms.
    Zoraghi R; Campbell S; Kim C; Dullaghan EM; Blair LM; Gillard RM; Reiner NE; Sperry J
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5059-62. PubMed ID: 25266785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.
    Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S
    Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors of the methicillin-resistant Staphylococcus aureus (MRSA)-pyruvate kinase.
    El-Sayed MT; Zoraghi R; Reiner N; Suzen S; Ohlsen K; Lalk M; Altanlar N; Hilgeroth A
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1666-71. PubMed ID: 26653005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Kumar NS; Dullaghan EM; Finlay BB; Gong H; Reiner NE; Jon Paul Selvam J; Thorson LM; Campbell S; Vitko N; Richardson AR; Zoraghi R; Young RN
    Bioorg Med Chem; 2014 Mar; 22(5):1708-25. PubMed ID: 24508307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-Resistant Staphylococcus Aureus (MRSA) Pyruvate Kinase (PK) Inhibitors and their Antimicrobial Activities.
    Jia J; Luo Y; Zhong X; He L
    Curr Med Chem; 2022; 29(5):908-923. PubMed ID: 33749550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Gong H; Lui SL; See RH; Jolivalt C; Fung KP; Leung PC; Reiner NE; Lau CB
    Phytomedicine; 2013 May; 20(7):611-4. PubMed ID: 23541215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
    Okamura S; Nishiyama E; Yamazaki T; Otsuka N; Taniguchi S; Ogawa W; Hatano T; Tsuchiya T; Kuroda T
    Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
    Jin J; Cui J; Chaudhary AS; Hsieh YH; Damera K; Zhang H; Yang H; Wang B; Tai PC
    Bioorg Med Chem; 2015 Nov; 23(21):7061-8. PubMed ID: 26432604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid.
    Bai H; Sang G; You Y; Xue X; Zhou Y; Hou Z; Meng J; Luo X
    PLoS One; 2012; 7(1):e29886. PubMed ID: 22253815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic analogues of the marine bisindole deoxytopsentin: potent selective inhibitors of MRSA pyruvate kinase.
    Veale CG; Zoraghi R; Young RM; Morrison JP; Pretheeban M; Lobb KA; Reiner NE; Andersen RJ; Davies-Coleman MT
    J Nat Prod; 2015 Mar; 78(3):355-62. PubMed ID: 25372480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.
    Ciustea M; Mootien S; Rosato AE; Perez O; Cirillo P; Yeung KR; Ledizet M; Cynamon MH; Aristoff PA; Koski RA; Kaplan PA; Anthony KG
    Biochem Pharmacol; 2012 Feb; 83(3):368-77. PubMed ID: 22146584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
    Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
    Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.